Protocol for a cluster randomised controlled feasibility study of Prehospital Optimal Shock Energy for Defibrillation (POSED)
•Evidence for best shock energy to treat out-of-hospital cardiac arrest is lacking.•POSED is a feasibility study for a future trial intended to close the evidence gap.•90 patients will be recruited within a single NHS Ambulance Service.•Feasibility will be tested by comparing numbers of eligible wit...
Saved in:
Published in: | Resuscitation plus Vol. 12; p. 100310 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Netherlands
Elsevier B.V
01-12-2022
Elsevier |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | •Evidence for best shock energy to treat out-of-hospital cardiac arrest is lacking.•POSED is a feasibility study for a future trial intended to close the evidence gap.•90 patients will be recruited within a single NHS Ambulance Service.•Feasibility will be tested by comparing numbers of eligible with recruited patients.•We will select best outcomes for a trial based on clinical relevance, reliability and ease of recording.
The Prehospital Optimal Shock Energy for Defibrillation (POSED) study will assess the feasibility of conducting a cluster randomised controlled study of clinical effectiveness in UK ambulance services to identify the optimal shock energy for defibrillation.
POSED is a pragmatic, allocation concealed, open label, cluster randomised, controlled feasibility study. Defibrillators within a single UK ambulance service will be randomised in an equal ratio to deliver one of three shock strategies 120–150–200 J, 150–200–200 J, 200–200–200 J. Consecutive adults (≥18 years) presenting with out of hospital cardiac arrest requiring defibrillation will be eligible. The study plans to enrol 90 patients (30 in each group). Patients (or their relatives for non-survivors) will be informed about trial participation after the initial emergency has resolved. Survivors will be invited to consent to participate in follow-up (i.e., at 30 days or discharge).
The primary feasibility outcome is the proportion of eligible patients who receive the randomised study intervention. Secondary feasibility outcomes will include recruitment rate, adherence to allocated treatment and data completeness. Clinical outcomes will include Return of an Organised Rhythm (ROOR) at 2 minutes post-shock, refibrillation rate, Return of Spontaneous Circulation (ROSC) at hospital handover, survival and neurological outcome at 30 days.
The POSED study will assess the feasibility of a large-scale trial and explore opportunities to optimise the trial protocol.
Trial registration: ISRCTN16327029. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 2666-5204 2666-5204 |
DOI: | 10.1016/j.resplu.2022.100310 |